KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Pharmacological Management

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Seminars in nephrology 2015-11, Vol.35 (6), p.582-589.e17
Hauptverfasser:	Mallett, Andrew, MB BS, MMed, AFRACMA, FRACP, Lee, Vincent W., MB BS, PhD, FRACP, Mai, Jun, MB BS, FRACP, Lopez-Vargas, Pamela, MPH, Rangan, Gopala K., MB BS, PhD, FRACP
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiotensin Receptor Antagonists - therapeutic use Angiotensin-Converting Enzyme Inhibitors - therapeutic use Antidiuretic Hormone Receptor Antagonists - therapeutic use Antihypertensive Agents - therapeutic use Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Mechanistic Target of Rapamycin Complex 1 Multiprotein Complexes - antagonists & inhibitors Nephrology Polycystic Kidney, Autosomal Dominant - drug therapy Polycystic Kidney, Autosomal Dominant - physiopathology Somatostatin - analogs & derivatives TOR Serine-Threonine Kinases - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!